Animal experiments have shown that the upregulation of PTGS2-induced inflammation can promote the progression of Alzheimer’s disease[16], and inhibiting the upregulation of PTGS2 can improve postoperative cognition[15]. The gene discussed is PTGS2; the disease is early-onset autosomal dominant Alzheimer disease.